-

Medical Device Manufacturers Non-Conformance and Corrective Action Training Course: Strengthen Root Cause Analysis and Improve QMS Compliance to Prevent Non-Conformance (ONLINE EVENT: Dec 11, 2025) - ResearchAndMarkets.com

DUBLIN--(BUSINESS WIRE)--The "Non-Conformance and Corrective Action for Medical Device Manufacturers Training Course (Dec 11, 2025)" training has been added to ResearchAndMarkets.com's offering.

This course provides an introduction to these regulatory requirements as they relate to the identification and handling of non-conformances and how manufacturers may demonstrate compliance.

The identification of non-conformances and ensuring that they are dealt with in a timely and appropriate manner is a key part of any medical device Quality Management System (QMS). Regulations for medical device quality management systems include particular requirements for non-conformance, correction, corrective and preventative actions.

These requirements relate to non-conformances identified through internal audits, external audits, routine processes, customer complaints vigilance and many other activities. Evidence of a QMS which deals with non-conformance and prevents recurrence is important and expected when demonstrating conformity with the regulations.

These requirements are defined in ISO 13485, the international standard for medical device quality management systems, as well as in 21 CFR 820 and other global regulations.

Benefits of Attending

  • Understand the sources of non-conformance within a medical device QMS
  • Learn techniques to establish the root cause of a non-conformance
  • Understand the difference between containment, correction, corrective action, and preventative action
  • Gain an awareness of the ways in which an effective Corrective and Preventative Action (CAPA) system can lead to improved performance and regulatory compliance

Who Should Attend:

  • Managers and supervisors working within a regulated Quality Management System (QMS)
  • Regulatory Compliance specialists
  • Quality Management System (QMS) specialists
  • Internal Auditors
  • Regulatory and Quality professionals

Certification:

  • CPD: 3 hours for your records
  • Certificate of completion

Key Topics Covered:

Non-Conformance and Corrective Action

  • Regulatory requirements for non-conformance and corrective action
  • Definitions and understanding CAPA
  • Sources of non-conformance and writing an effective statement of non-compliance
  • The non-conformance and corrective action cycle
  • Assessment of the risk associated with non-compliance
  • Root cause analysis tools and methodology
  • Correction, containment and impact assessment
  • Taking effective corrective action to address root causes
  • Evaluation of the effectiveness of corrective action
  • Use of electronic quality management systems for non-conformance management

Preventive Action

  • Regulatory requirements for identification of preventive action
  • Sources of preventive action and how to capture the details
  • Root cause analysis
  • Evaluation of the effectiveness of preventive action

Speakers:

Annette Callaghan

Sterile Management Systems

A quality management professional, chartered biologist and member of the Royal Society of Biology, with over 35 years' experience in the medical device, pharmaceutical, biotechnology and food industries. Extensive knowledge of quality and environmental management systems, internal and third-party auditing and personnel training. Eligible to act as a Qualified Person as defined in Directive 2001/83/EC, as amended (previously 75/319 et al.) since 1993. A Qualified Notified Body Lead Auditor since 2002 (IRCA ref: 1182641).

For more information about this training visit https://www.researchandmarkets.com/r/bws6ms

About ResearchAndMarkets.com

ResearchAndMarkets.com is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.

Contacts

ResearchAndMarkets.com
Laura Wood, Senior Press Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./ CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900

Research and Markets


Release Versions

Contacts

ResearchAndMarkets.com
Laura Wood, Senior Press Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./ CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900

More News From Research and Markets

Belgium Alternative Lending Databook Report 2025: Market to Grow by 16.6% to Reach $4.26 Billion - Forecast to 2029 - ResearchAndMarkets.com

DUBLIN--(BUSINESS WIRE)--The "Belgium Alternative Lending Market Size & Forecast by Value and Volume Across 100+ KPIs by Type of Lending, End-User Segments, Loan Purpose, Finance Models, Distribution Channels, and Payment Instruments - Databook Q4 2025 Update" report has been added to ResearchAndMarkets.com's offering. Alternative lending market in Belgium was expected to grow by 16.6% annually, reaching US$4.26 billion by 2025. The alternative lending market in the country has experienced...

Middle East B2C Ecommerce Databook Q4 2025: Market Size & Forecast by Value and Volume Across 80+ KPIs Through 2020-2029 - ResearchAndMarkets.com

DUBLIN--(BUSINESS WIRE)--The "Middle East B2C Ecommerce Market Size & Forecast by Value and Volume Across 80+ KPIs - Databook Q4 2025 Update" has been added to ResearchAndMarkets.com's offering. The ecommerce market in the Middle East and Africa (MEA) is positioned for substantial growth, with expectations to expand by 10% annually, achieving a market size of approximately US$146.9 billion by 2025. The region has displayed notable growth from 2020 to 2024 with a compound annual growth rate...

Drug Analytical Method Validation, Verification and Transfer Virtual Seminar (Jan 14th - Jan 15th, 2026 and On-Demand) - ResearchAndMarkets.com

DUBLIN--(BUSINESS WIRE)--The "Analytical Method Validation, Verification and Transfer Virtual Seminar (Jan 14th - Jan 15th, 2026)" training has been added to ResearchAndMarkets.com's offering. Dependable analytical results are essential to making a knowledgeable choice about the excellence and care of the products in the medicinal business. Additionally, such investigative data is required for supervisory submissions in the provision of the drug creation recordings. Therefore, expressive untrie...
Back to Newsroom